A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2
Vasiliki Bozionelou, Kostas Kalbakis, Lambros Vamvakas, Sofia Agelaki, Nikolaos Androulakis, Antonia Kalykaki, Vassilis Georgoulias, Dimitris MavroudisVolume:
64
Language:
english
Pages:
7
DOI:
10.1007/s00280-009-0928-6
Date:
September, 2009
File:
PDF, 275 KB
english, 2009